Oral Syringes Market Size, Share & Industry Analysis, By Product Type (Single Use, Home Use, Catheter Tip), By Application (Oncology, Gastro Intestinal Diseases, Neurological Diseases, Others), By End User (Hospitals, Speciality Clinics, Home Care) and Regional Forecast, 2024-2032

Oral syringes are mainly used to administer oral and enteral liquid medication in patients suffering from various health problems. Medicine administration through syringes reduces the chances of medication error. This in result, is prompting the increased usage of syringes by medical professionals which is also influencing the market growth. Enteral syringes are widely used for administering the drug through various routes which include rectal, oral, and sublingual especially for the patients admitted in critical care units, hospitals, NICU, and others. These syringes are available in different sizes such as 1ml, 5ml, 10ml, 20ml, 30ml, and 60ml which help in the proper route of drug administration by reducing medication errors. Syringes come with various safety features that include labeling that reads oral/enteral only. They have a purple plunger where purple color is used to differentiate between these syringes and IV syringes. Thus, they are often used to measure appropriate oral liquid medication that needs to be delivered to the patient during the situations when the medication cannot be measured using a medicine spoon or cup. As a result, these are syringes are used for all age groups of patients such as neonatal, pediatrics, adults, and geriatric for accurate administration of the drug for faster recovery which is propelling the growth of the market during the forecast period.

Major factors that are driving the growth of the market are an increase in usage of syringes by medical professionals for the proper administration of enteral feed, a rise in healthcare expenditure, a rise in patients suffering from various chronic diseases, increase in premature neonates admission in NICU, a rise in growth of geriatric patients, and others. According to, the Centres for Disease Control and Prevention, it is estimated that in the U.S alone every 6 in 10 adults have a chronic disease. In addition to this, according to the World Health Organisation, it is anticipated that global cases of cancer have risen by 18.1 million new cases and 9.6 million deaths in 2018. Furthermore, various other factors that are positively influencing the market growth are reduction in hospitalization time, reduced clinical complication oriented with drug administration, less possibility of bacterial infections, and others. In addition to this, these syringes are widely used in patients suffering from liver diseases, inflammatory bowel disease, cystic fibrosis, gastrointestinal mucosa, renal disease, and others which are augmenting the market growth during the forecast. Owing to an increase in the prevalence of all these diseases, improper nutritional supply to the body due to unhealthy eating habits, changes in societal behaviour, weak functioning of the digestive system, and others are contributing towards the increase in long term health problems.

Key Market Driver -

Increasing prevalence of chronic diseases

Key Market Restraint -

High complications associated with enteral feeding

However, various complications associated with enteral feeding insertion such as nasal damage, bronchial placement, gastrointestinal intolerance, and others are some of the clinical factors that are limiting the market. Moreover, delay in FDA approvals, stringent rules, and others are also hindering the market growth in the near future.

Key Players Covered:

Some of the major companies that are present in the global oral syringes market are B. Braun Melsungen AG, Cardinal Health, Smith & Nephew, Baxter, Avanos Corporate, BD, Medtronic, Smiths Medical, Inc., Terumo Corporation, and other players.

Single use syringes are anticipated to boost the market growth. Owing to increase in number of ICU admissions, a rise in medical professionals preferring enteral and oral syringes for drug administration, and others. Moreover, sanitization and increased concern of safety during drug administration is also contributing towards single time usage of syringes.

Key Insights

• Prevalence of Chronic Diseases


• Regulatory scenario for key countries


• New product launches


• Key industry developments

Regional Analysis:

The global oral syringes market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global oral syringes market due to a number of factors such as the increasing prevalence of chronic diseases, increased healthcare awareness, and presence of major key players in the region such as BD, Smiths Medical, and others. Europe is considered to be second dominating followed by the Asia Pacific due to increase in geriatric population, increased healthcare infrastructure, and others. Latin America and Middle East & Africa are expected to experience steady growth owing to unmet healthcare facilities, low healthcare expenditure, and others.

To gain extensive insights into the market, Request for Customization

Segmentation

Key Industry Developments

• In March 2017, Medela LLC introduced complete enteral feeding system named as ENFit low dose tip enteral syringes that help in accurate delivering of drug by reducing the error.